BSEBoard Meeting5d ago · 13 Oct 2026, 07:21 pm

Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve inter-alia the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026

HealthCare Global Enterprises Ltd · 539787

✦ AI SummaryResults

HealthCare Global Enterprises Ltd has scheduled a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2026.

Attachments (1)

📄

aa33968c-0607-4fb6-bb42-c7a153264fe9.pdf

pdf

Download →
View document text
October 13, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Intimation of the Meeting of Board of Directors of HealthCare Global Enterprises Limited (“the Company”). Stock Code : BSE – 539787, NSE – HCG Reference : Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) We would like to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, November 05, 2026, to consider and approve inter-alia the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026 (“Financial Results”). Further in accordance with the Company’s code of conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and amendments made thereunder, the trading window for dealing in shares of the Company is closed for all Designated Persons of the Company and their immediate relatives from October 01, 2026, and shall remain closed up to 48 hours after the declaration of the Financial Results. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/ You are requested to take the information on record. Thanking You, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary and Compliance Officer. HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag